Shattuck Labs, INC Form 4 insider transactions
NASDAQ
Redmile Group executed cross trades of Shattuck Labs stock at $1.25 per share, resulting in no profit and a reduction in beneficial ownership due to the cessation of an advisory role.
NASDAQ
Shattuck Labs' CEO, Taylor Schreiber, recently acquired 36,500 shares of the company's common stock at an average price of $1.2115.
NASDAQ
Director Tyler Brous of Shattuck Labs, Inc. [STTK] recently purchased additional shares of common stock, increasing his beneficial ownership.
NASDAQ
Shattuck Labs' CEO, Taylor Schreiber, recently purchased 14,400 shares of the company's common stock at an average price of $3.473 per share.
NASDAQ
Michael Stewart Lee, a director of Shattuck Labs, reports the acquisition of stock options representing the right to purchase 27,700 shares of common stock.
NASDAQ
Redmile Group, through managing director Michael Lee's board service, acquires stock options in Shattuck Labs, Inc., with Jeremy Green also potentially deemed a beneficial owner.
NASDAQ
Clay B. Siegall, a director at Shattuck Labs, acquired options to purchase 27,700 shares of common stock on June 21, 2024.
NASDAQ
Director Amy Kate Sasser acquired options to purchase 27,700 shares of Shattuck Labs common stock on June 21, 2024.
NASDAQ
Director George Golumbeski acquired options to purchase 27,700 shares of Shattuck Labs common stock on June 21, 2024.
NASDAQ
Director Neil W. Gibson acquired stock options for 27,700 shares of Shattuck Labs, Inc. on June 21, 2024.
NASDAQ
Director Helen M. Boudreau of Shattuck Labs, Inc. was granted stock options to purchase 27,700 shares of common stock on June 21, 2024.
NASDAQ
Director Carrie Brownstein reports the acquisition of stock options in Shattuck Labs.
NASDAQ
Director Tyler Brous of Shattuck Labs, Inc. reports the acquisition of stock options exercisable for 27,700 shares of common stock.
NASDAQ
Taylor Schreiber, CEO of Shattuck Labs, exercised stock options to acquire 3,050 shares of common stock at $3.57 per share.
NASDAQ
Stephen Stout, General Counsel, Corporate Secretary, and Chief Ethics and Compliance Officer of Shattuck Labs, disposed of 967 shares of common stock on May 10, 2024, to cover tax obligations.
NASDAQ
Redmile Group, LLC reports a pro rata in-kind distribution of 4,425 shares of Shattuck Labs, Inc. common stock, resulting in a change in beneficial ownership.
NASDAQ
Stephen Stout, General Counsel, Corporate Secretary, and Chief Ethics and Compliance Officer of Shattuck Labs, exercised stock options and sold shares of common stock on March 6, 2024, according to a Form 4 filing with the SEC.
NASDAQ
Clay B. Siegall, a director at Shattuck Labs, acquired options to purchase 33,409 shares of common stock on March 6, 2024.
NASDAQ
Director Amy Kate Sasser acquired options to purchase 33,409 shares of Shattuck Labs common stock on March 6, 2024.